George Hill
Stock Analyst at Deutsche Bank
(4.53)
# 1,046
Out of 4,988 analysts
626
Total ratings
54%
Success rate
8.8%
Average return
Main Sectors:
Stocks Rated by George Hill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLOV Clover Health Investments | Initiated Coverage: Buy | $6 | $4.46 | +34.53% | 1 | Sep 11, 2026 | |
| HQY HealthEquity | Rated: Buy | $128 → $142 | $95.14 | +49.25% | 25 | Aug 31, 2026 | |
| CAH Cardinal Health | Reiterated: Hold | $261 | $225.38 | +15.80% | 48 | Aug 13, 2026 | |
| DH Definitive Healthcare | Reiterated: Hold | $3 → $1 | $0.96 | +4.17% | 14 | Aug 12, 2026 | |
| HIMS Hims & Hers Health | Rated: Hold | $25 → $26 | $27.99 | -7.11% | 16 | Aug 11, 2026 | |
| EHTH eHealth | Reiterated: Hold | $3 → $2 | $0.889 | +124.97% | 24 | Aug 6, 2026 | |
| UNH UnitedHealth Group | Reiterated: Hold | n/a | $376.90 | - | 38 | Aug 3, 2026 | |
| CI The Cigna Group | Reiterated: Hold | $302 → $305 | $275.28 | +10.80% | 31 | Jul 31, 2026 | |
| WAY Waystar Holding | Rated: Buy | $37 → $39 | $25.66 | +51.99% | 5 | Jul 31, 2026 | |
| HUM Humana | Reiterated: Buy | $441 → $436 | $386.22 | +12.89% | 38 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $39 → $80 | $65.11 | +22.87% | 23 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $332 → $498 | $410.95 | +21.18% | 20 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $875 | $874.65 | +0.04% | 67 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $33 → $49 | $89.16 | -45.04% | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92 | $88.84 | +3.56% | 53 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $109 → $129 | $200.79 | -35.75% | 24 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $12 → $11 | $6.30 | +74.60% | 41 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $3 | $3.38 | -11.24% | 18 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $322 → $371 | $308.78 | +20.15% | 38 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $295 → $210 | $164.11 | n/a | 11 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $5 | $4.70 | n/a | 32 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $175 | $263.96 | n/a | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $255 → $250 | $266.42 | n/a | 20 | Mar 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $409 → $350 | $278.06 | n/a | 16 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $34.23 | n/a | 1 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $91 | $84.84 | n/a | 1 | Sep 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $131.77 | n/a | 1 | Oct 6, 2011 |
Clover Health Investments
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $4.46
Upside: +34.53%
HealthEquity
Aug 31, 2026
Rated: Buy
Price Target: $128 → $142
Current: $95.14
Upside: +49.25%
Cardinal Health
Aug 13, 2026
Reiterated: Hold
Price Target: $261
Current: $225.38
Upside: +15.80%
Definitive Healthcare
Aug 12, 2026
Reiterated: Hold
Price Target: $3 → $1
Current: $0.96
Upside: +4.17%
Hims & Hers Health
Aug 11, 2026
Rated: Hold
Price Target: $25 → $26
Current: $27.99
Upside: -7.11%
eHealth
Aug 6, 2026
Reiterated: Hold
Price Target: $3 → $2
Current: $0.889
Upside: +124.97%
UnitedHealth Group
Aug 3, 2026
Reiterated: Hold
Price Target: n/a
Current: $376.90
Upside: -
The Cigna Group
Jul 31, 2026
Reiterated: Hold
Price Target: $302 → $305
Current: $275.28
Upside: +10.80%
Waystar Holding
Jul 31, 2026
Rated: Buy
Price Target: $37 → $39
Current: $25.66
Upside: +51.99%
Humana
Jul 30, 2026
Reiterated: Buy
Price Target: $441 → $436
Current: $386.22
Upside: +12.89%
May 20, 2026
Upgraded: Buy
Price Target: $39 → $80
Current: $65.11
Upside: +22.87%
May 20, 2026
Upgraded: Buy
Price Target: $332 → $498
Current: $410.95
Upside: +21.18%
May 8, 2026
Reiterated: Buy
Price Target: $875
Current: $874.65
Upside: +0.04%
May 7, 2026
Upgraded: Buy
Price Target: $33 → $49
Current: $89.16
Upside: -45.04%
May 7, 2026
Reiterated: Buy
Price Target: $92
Current: $88.84
Upside: +3.56%
Apr 24, 2026
Reiterated: Hold
Price Target: $109 → $129
Current: $200.79
Upside: -35.75%
Mar 10, 2026
Upgraded: Buy
Price Target: $12 → $11
Current: $6.30
Upside: +74.60%
Feb 27, 2026
Reiterated: Hold
Price Target: $6 → $3
Current: $3.38
Upside: -11.24%
Nov 7, 2025
Reiterated: Buy
Price Target: $322 → $371
Current: $308.78
Upside: +20.15%
Jul 29, 2025
Reiterated: Buy
Price Target: $295 → $210
Current: $164.11
Upside: n/a
Mar 27, 2025
Reiterated: Hold
Price Target: $10 → $5
Current: $4.70
Upside: n/a
Jun 28, 2024
Reiterated: Hold
Price Target: $175
Current: $263.96
Upside: n/a
Mar 22, 2022
Reiterated: Buy
Price Target: $255 → $250
Current: $266.42
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $409 → $350
Current: $278.06
Upside: n/a
May 6, 2020
Reiterated: Hold
Price Target: $68
Current: $34.23
Upside: n/a
Sep 19, 2017
Initiated Coverage: Hold
Price Target: $91
Current: $84.84
Upside: n/a
Oct 6, 2011
Upgraded: Buy
Price Target: n/a
Current: $131.77
Upside: n/a